ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Course of BK Virus Infection in Renal Transplant Recipients Treated with Cidofovir

    S. Kuten, S. Patel, R. Knight, L. Gaber, A. Gaber

    The Methodist Hospital, Houston, TX

    In renal transplantation, BK virus may contribute to graft dysfunction and graft loss. While reduction in immunosuppression is considered standard therapy for infection, data has…
  • 2013 American Transplant Congress

    First Report of Experience Using Telaprevir with Peginterferon and Ribavirin To Treat Recurrent Hepatitis C Genotype 1 in Recipients of Liver and Kidney Transplantation

    S. Pungpapong, R. Satyanarayana, B. Rosser, M. Yataco, M. Mai, H. Wadei, T. Gonwa, A. Keaveny

    Transplantation, Mayo Clinic, Jacksonville, FL

    Background: Recurrent hepatitis C (HCV) after liver transplantation (LT) is universal and may lead to poor outcomes. Treatment with peginterferon and ribavirin (PR) after LT…
  • 2013 American Transplant Congress

    First Canadian Experience in Pediatric En-Bloc Renal Allograft Donation after Cardiac Death

    N. Rowe, M. Dion, J. Shum, C. Weernink, A. Sener, P. Luke

    Urology, Western University, London, ON, Canada; Surgery, Western University, London, ON, Canada

    Introduction: The use of small pediatric kidneys obtained from donors less than four years of age after cardiac death (DCD) has been limited. This is…
  • 2013 American Transplant Congress

    Estimated Glomerular Filtration Rate Decreases Transiently Following Repeat Heart Transplantation in Children and Young Adults

    J. Gralla, S. Auerbach, C. Connell, M. Mitchell, D. Campbell, J. Jaggers, S. Miyamoto, B. Pietra

    University of Colorado Denver, Aurora

    Background: Renal function is abnormal in patients with end stage graft failure due to hemodynamic compromise and chronic exposure to nephrotoxic medications. The purpose of…
  • 2013 American Transplant Congress

    Salvage Transplantation Aligns Survival for Small and Large Hepatocellular Carcinomas in the Modern Era of Liver Surgery

    M. Kluger, J. Salceda, A. Laurent, C. Tayar, D. Azoulay, D. Cherqui

    HPB Surgery & Liver Transplantation, NYPH-Weill Cornell Medical Center, New York; Chirurgie Hépatobiliaire, Hôpital Henri Mondor, Créteil, France

    INTRODUCTIONOperative management is standard treatment of hepatocellular carcinoma (HCC). In select patients, resection can offer cure or a bridge to transplantation. This study analyzed resection…
  • 2013 American Transplant Congress

    Protective Effect of Carbon Monoxide-Releasing Molecules in Renal Ischemia-Reperfusion Injury Is Associated with Profound Inhibition of HMGB1 Cytoplasmic Translocation, The

    G. Chen, Y. Ruan, L. Wang, Y. Xiang, H. Guo, Y. Zhao

    Institue of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Background: carbon monoxide-releasing molecules (CORMs) can significantly protect against renal ischemia-reperfusion injury (IRI), however, the mechanisms have not been fully elucidated. HMGB1 can be passively…
  • 2013 American Transplant Congress

    Network Analysis Reveals Roles of Inflammation Factors in Different Phenotypes of Kidney Transplantation Patients

    D. Wu, M. Qian, M. Xu, R. Rong, T. Zhu

    Zhongshan Hospital, Fudan University, Shanghai Key Lab of Organ Transplantation, Shanghai, China

    BackgroundSystems-level characterization of inflammation in kidney transplantation remains incomplete. The present study aimed at identifying the inflammation proteins in phenotype transformation and assessing potential biomarkers…
  • 2013 American Transplant Congress

    Outcomes on the Simultaneous Pancreas-Kidney (SPK) Transplant Waitlist: A Competing Risk Analysis of the UNOS Database

    C. Schulze, M. Kamgar, E. Huang, G. Danovitch, S. Bunnapradist

    Kidney Transplant Research Center, UCLA David Geffen School of Medicine, Los Angeles, CA

    Objective: To determine the risk of competing outcomes for patients on the waitlist for Simultaneous Pancreas-Kidney (SPK) transplantation.Design: We used the OPTN/UNOS database to examine…
  • 2013 American Transplant Congress

    Donor CISH Polymorphism Is Associated with Allograft Outcomes in Kidney Transplantation

    S. Baek, J. Jeong, T. Koo, H. Kwon, Y. Kim, H. Park, M. Kim, H. Ro, Y. Hwang, C. Ahn, J. Yang

    Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Transplantation Research Institute, Seoul National University, Seoul, Korea; Department of Internal Medicine, Eulji General Hospital, Seoul, Korea; Transplantation Center, Seoul National University Hospital, Seoul, Korea

    Background: Cytokine-inducible SH-2 containing protein (CISH) is a member of suppressor of cytokine signaling (SOCS) family and involved in the negative regulation of IL-2 mediated…
  • 2013 American Transplant Congress

    Analysis of miRNAs in Peripheral Blood Mononuclear Cells: Potential Value of miR-182 as a Biomarker of Chronic Antibody Mediated Rejection

    K. Iwasaki, J. Ping, T. Yamamoto, Y. Miwa, M. Haneda, Y. Watarai, A. Katayama, K. Uchida, T. Kobayashi

    Department of Transplant Immunology, Nagoya University School of Medicine, Nagoya, Japan; Nagoya Daini Red Cross Hospital, Nagoya, Japan; Masuko Memorial Hospital, Nagoya, Japan

    [Purpose] All donor specific antibodies (DSAs) cannot cause chronic antibody-mediated rejection (CAMR), as grafts of renal transplant recipients with DSAs have shown different outcomes. Although…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences